Early Detection of Complications During Immunotherapy for Haematological Malignancy
Recruiting
N/A
Interventional Study
Hematologic Cancer
CRS - Cytokine Release Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Aims
* To identify patients that should remain admitted in hospital for more intense surveillance because of high risk for development of clinical complications
* Expand the understanding of the interactions between physiology and immunology for the design of future projects and general knowledge Hypothesis Development of a risk model based on a combination of physiological and immunological para…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Patients diagnosed with haematologic malignant disease (e.g. malignant lymphoma)
* Patients scheduled for treatment with CART or BsAbs
Exclusion Criteria:
* Patient is pregnant
* Patient has a pacemaker
* Patient is allergic to one or more of the materials t…
Contacts